Synlett 1994; 1994(12): 998-1000
DOI: 10.1055/s-1994-34982
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

New Synthetic Approach to the Western Part C10-C15 of (±)-Des-Epoxy-Rosaramycin

Patrick Le Ménez* , Isabelle Berque, Valérie Fargeas, Janick Ardisson, Ange Pancrazi
  • *Laboratoire de Chimie des Substances Thérapeutiques Naturelles, (CNRS, BIOCIS, URA 1843), Centre d'Etudes Pharmaceutiques, 92290, Châtenay-Malabry, France.
Further Information

Publication History

Publication Date:
22 March 2002 (online)

A new route to (5E,7E,3R*,4S*)-4, 6-dimethyl-8-tri-n-butylstannyl-octa-5,7-dien-3-ol 5 which represents the western part C10-C15 of the macrocyclic antibiotic (±)-des-epoxy-rosaramycin I, was explored. Direct model catalytic palladium coupling reaction between (3E)-4-iodo-pent-3-en-1-ol 8 and (E)-1,2bis (tri-n-butylstannyl) ethylene gave (3E,5E )-4-methyl-6-tributylstannyl-hex-3,5-dien-1-ol 4 in 36% yield. Stannyl cupration performed on the (5E,3R*,4S*)-4,6-dimethyl-oct-5-en-7-yn-3-ol 15 led in high yield to the expected stannyl diene 5.

    >